Sensei Biotherapeutics Inc expected to post a loss of 35  cents a share - Earnings Preview

Faeth Therapeutics,

06/05/2022 12:40

* Sensei Biotherapeutics Inc  SNSE.OQ   SNSE.O  is expected
to show no change in quarterly revenue when it reports 
results on May 10 (estimated). 
    * ​Refinitiv's mean analyst estimate for Sensei
Biotherapeutics
Inc is for a loss of 35 cents per share. For the same quarter
last year, the company reported a loss of 42 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $8​, above​ its last closing price
of $1.60. ​​​

This summary was machine generated May 6 at 11:40 GMT.  All
figures in US dollars  unless otherwise stated